Additionally, circulatory levels of HMGB1, S100A8, and S100A9 at the onset of AE-IPF are significantly increased compared to the levels at diagnosis of IPF, and the high levels also result in poorer survival in patients with AE-IPF [3–5]. Here, HMGB1 is linked to idiopathic pulmonary fibrosis.